{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:40:13Z","timestamp":1761183613818,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22mk0101173","22mk0101183"],"award-info":[{"award-number":["22mk0101173","22mk0101183"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.dmpk.2023.100495","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:44:45Z","timestamp":1675881885000},"page":"100495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Validation of a genotyping technique for a surrogate marker of HLA-B58:01 for allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in the Japanese population"],"prefix":"10.1016","volume":"49","author":[{"given":"Eri","family":"Tsukagoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-3798","authenticated-orcid":false,"given":"Ryosuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-1293","authenticated-orcid":false,"given":"Yoichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3767-7686","authenticated-orcid":false,"given":"Masahiro","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1971-9835","authenticated-orcid":false,"given":"Hideo","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-8152","authenticated-orcid":false,"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2023.100495_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1346-8138.2010.01196.x","article-title":"Pharmacogenetics of cutaneous adverse drug reactions","volume":"38","author":"Aihara","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib3","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"137","author":"Frey","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.dmpk.2023.100495_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/1346-8138.12925","article-title":"Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"42","author":"Aihara","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.alit.2015.05.002","article-title":"Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"64","author":"Kaniwa","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.dmpk.2023.100495_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/08820538.2015.1114841","article-title":"Chronic ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: the role of systemic immunomodulatory therapy","volume":"31","author":"Chang","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.dmpk.2023.100495_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2133\/dmpk.25.122","article-title":"Prediction of severe adverse drug reactions using pharmacogenetic biomarkers","volume":"25","author":"Tohkin","year":"2010","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100495_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/jhg.2013.37","article-title":"Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury","volume":"58","author":"Kaniwa","year":"2013","journal-title":"J\u00a0Hum Genet"},{"issue":"2","key":"10.1016\/j.dmpk.2023.100495_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cpt.2008","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing: 2020 update","volume":"109","author":"Karnes","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2023.100495_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib13","first-page":"656","article-title":"Allopurinol-induced DRESS syndrome","volume":"7","author":"Markel","year":"2005","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.dmpk.2023.100495_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","article-title":"Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012","volume":"36","author":"Ramasamy","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.dmpk.2023.100495_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt.1071","article-title":"The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA label","volume":"105","author":"Wang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2023.100495_bib16","doi-asserted-by":"crossref","first-page":"h4848","DOI":"10.1136\/bmj.h4848","article-title":"Use of HLA-B\u221758:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study","volume":"351","author":"Ko","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.dmpk.2023.100495_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/clpt.2012.209","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing","volume":"93","author":"Hershfield","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2023.100495_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpt.161","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update","volume":"99","author":"Saito","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2023.100495_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.644154","article-title":"Implementation of pharmacogenomic information on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"8","author":"Tsukagoshi","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.dmpk.2023.100495_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2012.01881.x","article-title":"HLA DNA typing: past, present, and future","volume":"80","author":"Erlich","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.dmpk.2023.100495_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12864-017-3575-z","article-title":"2.7 million samples genotyped for HLA by next generation sequencing: lessons learned","volume":"18","author":"Sch\u00f6fl","year":"2017","journal-title":"BMC Genom"},{"key":"10.1016\/j.dmpk.2023.100495_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-0039.2011.01649.x","article-title":"Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity","volume":"78","author":"Kostenko","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.dmpk.2023.100495_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bjd.12097","article-title":"Detection of HLA-B\u221758:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification","volume":"168","author":"Kwok","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/cts.12365","article-title":"Genotyping HLA-B\u22175801 for allopurinol-induced severe cutaneous adverse reactions: an accurate and prompt method","volume":"8","author":"Cheng","year":"2015","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.dmpk.2023.100495_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2217\/pgs.15.185","article-title":"Validation of a rapid test for HLA-B\u221758:01\/57:01 allele screening to detect individuals at risk for drug-induced hypersensitivity","volume":"17","author":"Nguyen","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmpk.2023.100495_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4168\/aair.2017.9.1.79","article-title":"Validation of a rapid, robust, inexpensive screening method for detecting the HLA-B\u221758:01 allele in the prevention of allopurinol-induced severe cutaneous adverse reactions","volume":"9","author":"Nguyen","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.dmpk.2023.100495_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A\u00a0whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"13","author":"Tohkin","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.dmpk.2023.100495_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2133\/dmpk.DMPK-11-NT-120","article-title":"Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B\u221758:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome\/toxic epidermal necrolysis in Japanese","volume":"27","author":"Maekawa","year":"2012","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100495_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.dmpk.2018.08.003","article-title":"Development and application of a rapid and sensitive genotyping method for pharmacogene variants using the single-stranded tag hybridization chromatographic printed-array strip (STH-PAS)","volume":"33","author":"Kumondai","year":"2018","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100495_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248536","article-title":"Rapid detection of extended spectrum beta-lactamase producing Escherichia coli isolated from fresh pork meat and pig cecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis","volume":"16","author":"Kanokudom","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.dmpk.2023.100495_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7883\/yoken.JJID.2020.754","article-title":"Rapid and simple detection of isoniazid-resistant Mycobacterium tuberculosis utilizing a DNA chromatography-based technique","volume":"74","author":"Kodera","year":"2021","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.dmpk.2023.100495_bib32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmpk.2023.100495_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.dmpk.2023.100495_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2023.100495_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2023.100495_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/jhg.2015.23","article-title":"Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies","volume":"60","author":"Kamitsuji","year":"2015","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.dmpk.2023.100495_bib37","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmpk.2023.100495_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"year":"2020","series-title":"Guidelines for the validation of analytical methods for nucleic Acid sequence-based analysis of Food, feed, Cosmetics and veterinary products","key":"10.1016\/j.dmpk.2023.100495_bib39"},{"year":"2021","key":"10.1016\/j.dmpk.2023.100495_bib40"},{"key":"10.1016\/j.dmpk.2023.100495_bib41","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.dmpk.2023.100495_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2738784","article-title":"Comparison between the HLA-B\u221758:01 Allele and single-nucleotide polymorphisms in chromosome 6 for prediction of allopurinol-induced severe cutaneous adverse reactions","volume":"2017","author":"Saksit","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.dmpk.2023.100495_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-6-52","article-title":"Genome-wide association study of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe","volume":"6","author":"G\u00e9nin","year":"2011","journal-title":"Orphanet J Rare Dis"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:57:13Z","timestamp":1761163033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436723000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":43,"alternative-id":["S1347436723000071"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100495","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a genotyping technique for a surrogate marker of HLA-B\u221758:01 for allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in the Japanese population","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100495"}}